290 related articles for article (PubMed ID: 33567896)
21. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
Hang JF; Lilo MT; Bishop JA; Ali SZ
Acta Cytol; 2017; 61(2):117-124. PubMed ID: 28259878
[TBL] [Abstract][Full Text] [Related]
23. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.
Eszlinger M; Ullmann M; Ruschenburg I; Böhme K; Görke F; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Paschke R
Thyroid; 2017 Nov; 27(11):1385-1392. PubMed ID: 28982301
[TBL] [Abstract][Full Text] [Related]
24. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS/FLUS Thyroid Nodules.
Remer LF; Linhares SM; Scola WH; Lew JI
J Surg Res; 2023 Sep; 289():229-233. PubMed ID: 37148856
[TBL] [Abstract][Full Text] [Related]
25. Outcome of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid fine-needle aspirations: A six-year institutional experience.
Xu XM; Angelova E; Clement CG
Diagn Cytopathol; 2021 Aug; 49(8):915-920. PubMed ID: 33973739
[TBL] [Abstract][Full Text] [Related]
26. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
27. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
28. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
[No Abstract] [Full Text] [Related]
29. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
Lew JI; Snyder RA; Sanchez YM; Solorzano CC
J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
[TBL] [Abstract][Full Text] [Related]
30. Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules.
Elomami A; Elhag SA; Alseddeeqi E
Acta Cytol; 2021; 65(3):205-212. PubMed ID: 33524971
[TBL] [Abstract][Full Text] [Related]
31. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
Lale SA; Morgenstern NN; Chiara S; Wasserman P
Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
[TBL] [Abstract][Full Text] [Related]
32. Repeat Fine-Needle Aspiration With Molecular Analysis in Management of Indeterminate Thyroid Nodules.
Papazian MR; Dublin JC; Patel KN; Oweity T; Jacobson AS; Brandler TC; Givi B
Otolaryngol Head Neck Surg; 2023 Apr; 168(4):738-744. PubMed ID: 35412868
[TBL] [Abstract][Full Text] [Related]
33. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
Desai D; Lepe M; Baloch ZW; Mandel SJ
Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
[TBL] [Abstract][Full Text] [Related]
34. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
35. Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS).
Mulita F; Plachouri MK; Liolis E; Vailas M; Panagopoulos K; Maroulis I
Endokrynol Pol; 2021; 72(2):143-144. PubMed ID: 33749812
[TBL] [Abstract][Full Text] [Related]
36. Should we wait 3 months for a repeat aspiration in non-diagnostic/indeterminate thyroid nodules? A cancer centre experience.
Valerio E; Pastorello RG; Calsavara V; Porfírio MM; Engelman GG; Francisco Dalcin J; Bovolim G; Domingos T; De Brot L; Saieg M
Cytopathology; 2020 Nov; 31(6):525-532. PubMed ID: 32656878
[TBL] [Abstract][Full Text] [Related]
37. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
Rosario PW
Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
[TBL] [Abstract][Full Text] [Related]
38. Thyroid Atypia/Follicular Lesion of Undetermined Significance: Attitudes towards the Diagnosis of Bethesda System III Nodules.
Estrada Muñoz L; Díaz Del Arco C; Ortega Medina L; Fernández Aceñero MJ
Acta Cytol; 2017; 61(1):21-26. PubMed ID: 27852075
[TBL] [Abstract][Full Text] [Related]
39. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
40. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
